MedTrace Logo

The Prevention of Thromboembolic Complications Associated With Coil Embolization

NCT05512546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-08-23

No results posted yet for this study

Summary

Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.

Conditions

  • Thromboembolic Stroke
  • Aspirin
  • Clopidogrel
  • Coil Embolization
  • Prevention

Interventions

DRUG

Aspir-Low Pill

patients were prescribed 75 mg/day of either aspirin

Sponsors & Collaborators

  • Muhammad Hassan

    lead OTHER

Principal Investigators

  • Umair Rasheed, FRCPS · Lahore General Hospital

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2020-02-10
Completion
2020-12-10
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05512546 on ClinicalTrials.gov